1	Postoperative	Postoperative	B-NP	JJ	O	2	NMOD	0
2	progression	progression	I-NP	NN	O	0	ROOT	17	progression
3	of	of	B-PP	IN	O	2	NMOD	0
4	pulmonary	pulmonary	B-NP	JJ	O	5	NMOD	0
5	metastasis	metastasis	I-NP	NN	O	3	PMOD	14	metastasis
6	in	in	B-PP	IN	O	2	NMOD	0
7	osteosarcoma	osteosarcoma	B-NP	NN	O	6	PMOD	0
8	.	.	O	.	O	2	P	0

1	Early	Early	B-NP	RB	O	2	NMOD	0
2	relapse	relapse	I-NP	NN	O	7	SUB	0
3	with	with	B-PP	IN	O	2	NMOD	0
4	distant	distant	B-NP	JJ	O	5	NMOD	0
5	metastasis	metastasis	I-NP	NN	O	3	PMOD	14	metastasis
6	often	often	B-ADVP	RB	O	7	VMOD	0
7	is	be	B-VP	VBZ	O	0	ROOT	0
8	observed	observe	I-VP	VBN	O	7	VC	0
9	in	in	B-PP	IN	O	8	VMOD	0
10	patients	patient	B-NP	NNS	O	9	PMOD	0
11	with	with	B-PP	IN	O	10	NMOD	0
12	cancer	cancer	B-NP	NN	O	11	PMOD	0
13	after	after	B-PP	IN	O	10	NMOD	0
14	resection	resection	B-NP	NN	O	13	PMOD	19	resection
15	of	of	B-PP	IN	O	14	NMOD	0
16	the	the	B-NP	DT	O	18	NMOD	0
17	primary	primary	I-NP	JJ	O	18	NMOD	0
18	tumor	tumor	I-NP	NN	O	15	PMOD	0
19	.	.	O	.	O	7	P	0

1	It	It	B-NP	PRP	O	2	SUB	0
2	is	be	B-VP	VBZ	O	0	ROOT	0
3	considered	consider	I-VP	VBN	O	2	VC	0
4	that	that	B-SBAR	IN	O	3	VMOD	0
5	resection	resection	B-NP	NN	O	10	SUB	19	resection
6	of	of	B-PP	IN	O	5	NMOD	0
7	the	the	B-NP	DT	O	9	NMOD	0
8	primary	primary	I-NP	JJ	O	9	NMOD	0
9	tumor	tumor	I-NP	NN	O	6	PMOD	0
10	induces	induce	B-VP	VBZ	O	4	SBAR	17	induces
11	activation	activation	B-NP	NN	O	10	OBJ	17	activation
12	of	of	B-PP	IN	O	11	NMOD	0
13	systemic	systemic	B-NP	JJ	O	14	NMOD	0
14	angiogenesis	angiogenesis	I-NP	NN	O	12	PMOD	3	angiogenesis
15	and	and	O	CC	O	10	VMOD	0
16	enhances	enhance	B-VP	VBZ	O	10	VMOD	17	enhances
17	progression	progression	B-NP	NN	O	16	OBJ	17	progression
18	of	of	B-PP	IN	O	17	NMOD	0
19	remote	remote	B-NP	JJ	O	20	NMOD	0
20	metastasis	metastasis	I-NP	NN	O	18	PMOD	14	metastasis
21	.	.	O	.	O	2	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	authors	author	I-NP	NNS	O	3	SUB	0
3	show	show	B-VP	VBP	O	0	ROOT	0
4	that	that	B-SBAR	IN	O	3	VMOD	0
5	resection	resection	B-NP	NN	O	11	SUB	19	resection
6	of	of	B-PP	IN	O	5	NMOD	0
7	the	the	B-NP	DT	O	10	NMOD	0
8	primary	primary	I-NP	JJ	O	10	NMOD	0
9	osteosarcoma	osteosarcoma	I-NP	NN	O	10	NMOD	0
10	tumor	tumor	I-NP	NN	O	6	PMOD	0
11	enhances	enhance	B-VP	VBZ	O	4	SBAR	17	enhances
12	progression	progression	B-NP	NN	O	11	OBJ	17	progression
13	of	of	B-PP	IN	O	12	NMOD	0
14	pulmonary	pulmonary	B-NP	JJ	O	15	NMOD	0
15	metastasis	metastasis	I-NP	NN	O	13	PMOD	14	metastasis
16	in	in	B-PP	IN	O	12	NMOD	0
17	animal	animal	B-NP	NN	O	19	NMOD	0
18	osteosarcoma	osteosarcoma	I-NP	NN	O	19	NMOD	0
19	models	model	I-NP	NNS	O	16	PMOD	0
20	.	.	O	.	O	3	P	0

1	Matrigel	Matrigel	B-NP	NNP	O	4	NMOD	0
2	plug	plug	I-NP	NN	O	4	NMOD	0
3	neovascularization	neovascularization	I-NP	NN	O	4	NMOD	3	neovascularization
4	assay	assay	I-NP	NN	O	5	SUB	0
5	revealed	reveal	B-VP	VBD	O	0	ROOT	0
6	that	that	B-SBAR	IN	O	5	VMOD	0
7	systemic	systemic	B-NP	JJ	O	9	NMOD	0
8	angiogenic	angiogenic	I-NP	JJ	O	9	NMOD	3	angiogenic
9	activity	activity	I-NP	NN	O	10	SUB	0
10	was	be	B-VP	VBD	O	6	SBAR	0
11	elevated	elevate	I-VP	VBN	O	10	VC	17	elevated
12	after	after	B-PP	IN	O	11	VMOD	0
13	primary	primary	B-NP	JJ	O	15	NMOD	0
14	tumor	tumor	I-NP	NN	O	15	NMOD	0
15	removal	removal	I-NP	NN	O	12	PMOD	19	removal
16	(	(	O	(	O	34	DEP	0
17	tumor	tumor	B-NP	NN	O	19	NMOD	0
18	intact	intact	I-NP	JJ	O	19	NMOD	0
19	group	group	I-NP	NN	O	24	NMOD	0
20	,	,	O	,	O	24	P	0
21	1.61	1.61	B-NP	CD	O	23	AMOD	0
22	+/-	+/-	I-NP	SYM	O	23	AMOD	0
23	0.21	0.21	I-NP	CD	O	24	NMOD	0
24	g/dL	g/dL	I-NP	NN	O	27	SUB	0
25	;	;	O	:	O	27	P	0
26	tumor	tumor	B-NP	NN	O	27	SUB	0
27	removed	remove	B-VP	VBD	O	34	DEP	0
28	group	group	B-NP	NN	O	33	NMOD	0
29	,	,	O	,	O	33	P	0
30	4.92	4.92	B-NP	CD	O	32	AMOD	0
31	+/-	+/-	I-NP	SYM	O	32	AMOD	0
32	0.35	0.35	I-NP	CD	O	33	NMOD	0
33	g/dL	g/dL	I-NP	NN	O	27	OBJ	0
34	)	)	O	)	O	15	NMOD	0
35	.	.	O	.	O	5	P	0

1	In	In	B-PP	IN	O	13	VMOD	0
2	addition	addition	B-NP	NN	O	1	PMOD	0
3	,	,	O	,	O	13	P	0
4	serum	serum	B-NP	NN	O	5	NMOD	0
5	concentration	concentration	I-NP	NN	O	13	SUB	0
6	of	of	B-PP	IN	O	5	NMOD	0
7	the	the	B-NP	DT	O	9	NMOD	0
8	angiogenesis	angiogenesis	I-NP	NN	O	9	NMOD	3	angiogenesis
9	inhibitor	inhibitor	I-NP	NN	O	11	NMOD	0
10	,	,	O	,	O	11	P	0
11	endostatin	endostatin	B-NP	NN	O	6	PMOD	0
12	,	,	O	,	O	5	P	0
13	decreased	decrease	B-VP	VBD	O	0	ROOT	18	decreased
14	significantly	significantly	B-ADVP	RB	O	13	VMOD	0
15	after	after	B-PP	IN	O	13	VMOD	0
16	primary	primary	B-NP	JJ	O	18	NMOD	0
17	tumor	tumor	I-NP	NN	O	18	NMOD	0
18	removal	removal	I-NP	NN	O	15	PMOD	19	removal
19	.	.	O	.	O	13	P	0

1	Treatment	Treatment	B-NP	NN	O	7	SUB	19	Treatment
2	with	with	B-PP	IN	O	1	NMOD	0
3	the	the	B-NP	DT	O	6	NMOD	0
4	antiangiogenic	antiangiogenic	I-NP	JJ	O	6	NMOD	3	angiogenic
5	reagent	reagent	I-NP	NN	O	6	NMOD	0
6	TNP-470	TNP-470	I-NP	NN	O	2	PMOD	0
7	suppressed	suppress	B-VP	VBD	O	0	ROOT	18	suppressed
8	postoperative	postoperative	B-NP	JJ	O	9	NMOD	0
9	progression	progression	I-NP	NN	O	7	OBJ	17	progression
10	of	of	B-PP	IN	O	9	NMOD	0
11	pulmonary	pulmonary	B-NP	JJ	O	12	NMOD	0
12	metastasis	metastasis	I-NP	NN	O	10	PMOD	14	metastasis
13	.	.	O	.	O	7	P	0

1	These	These	B-NP	DT	O	2	NMOD	0
2	results	result	I-NP	NNS	O	3	SUB	0
3	indicate	indicate	B-VP	VBP	O	0	ROOT	0
4	the	the	B-NP	DT	O	5	NMOD	0
5	possibility	possibility	I-NP	NN	O	3	OBJ	0
6	that	that	B-SBAR	IN	O	5	NMOD	0
7	activation	activation	B-NP	NN	O	16	SUB	17	activation
8	of	of	B-PP	IN	O	7	NMOD	0
9	angiogenic	angiogenic	B-NP	JJ	O	10	NMOD	3	angiogenic
10	activity	activity	I-NP	NN	O	8	PMOD	0
11	after	after	B-PP	IN	O	7	NMOD	0
12	resection	resection	B-NP	NN	O	11	PMOD	19	resection
13	of	of	B-PP	IN	O	12	NMOD	0
14	osteosarcoma	osteosarcoma	B-NP	NN	O	15	NMOD	0
15	tumors	tumor	I-NP	NNS	O	13	PMOD	0
16	enhances	enhance	B-VP	VBZ	O	6	SBAR	17	enhances
17	progression	progression	B-NP	NN	O	16	OBJ	17	progression
18	of	of	B-PP	IN	O	17	NMOD	0
19	pulmonary	pulmonary	B-NP	JJ	O	20	NMOD	0
20	metastasis	metastasis	I-NP	NN	O	18	PMOD	14	metastasis
21	.	.	O	.	O	3	P	0

1	The	The	B-NP	DT	O	3	NMOD	0
2	current	current	I-NP	JJ	O	3	NMOD	0
3	data	datum	I-NP	NNS	O	5	SUB	0
4	also	also	B-ADVP	RB	O	5	VMOD	0
5	suggest	suggest	B-VP	VBP	O	0	ROOT	0
6	that	that	B-SBAR	IN	O	5	VMOD	0
7	administration	administration	B-NP	NN	O	11	SUB	19	administration
8	of	of	B-PP	IN	O	7	NMOD	0
9	antiangiogenic	antiangiogenic	B-NP	JJ	O	10	NMOD	3	angiogenic
10	reagents	reagent	I-NP	NNS	O	8	PMOD	0
11	can	can	B-VP	MD	O	6	SBAR	0
12	prevent	prevent	I-VP	VB	O	11	VC	18	prevent
13	progression	progression	B-NP	NN	O	12	OBJ	17	progression
14	of	of	B-PP	IN	O	13	NMOD	0
15	pulmonary	pulmonary	B-NP	JJ	O	16	NMOD	0
16	metastasis	metastasis	I-NP	NN	O	14	PMOD	14	metastasis
17	in	in	B-PP	IN	O	13	NMOD	0
18	osteosarcoma	osteosarcoma	B-NP	NN	O	17	PMOD	0
19	postoperatively	postoperatively	B-ADVP	RB	O	12	VMOD	0
20	.	.	O	.	O	5	P	0

